VUAB Pharma a.s.

VUAB Pharma a.s. focuses on metastatic and locally advanced solid tumors in settings where standard therapy is unavailable or has failed, with interest spanning lung cancer, head and neck cancer, colorectal cancer, gastric cancer, esophageal cancer, and breast cancer.

• Metastatic solid tumors
• Locally advanced malignancies
• Lung and head and neck cancers
• Gastrointestinal cancers
• Breast and gynecologic cancers

The sponsor’s clinical interest also includes ovarian cancer, fallopian tube cancer, and primary peritoneal high-grade serous carcinoma, reflecting a therapeutic focus on difficult-to-treat solid tumors.